ARCHIVES

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Director’s Office Gets Makeover In Reorganization Plan.

December 8, 2006

When Screening Mammography Meets Health Care Reform, Opinions Proliferate

February 4, 1994

Shift Towards More Treatable AIDS Lymphomas Identified

July 25, 2003

Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says.

May 7, 2004

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004

ICCCR to Focus Its Efforts on Prevention Research

February 22, 1991